08/21/2025
3:05 PM | MAHON PAUL A (Reporting)
United Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
08/07/2025
3:42 PM | MAHON PAUL A (Reporting)
United Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
08/01/2025
4:17 PM | United Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/30/2025
5:40 AM | United Therapeutics (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
07/30/2025
5:36 AM | United Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/30/2025
5:34 AM | United Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
07/25/2025
5:56 PM | MAHON PAUL A (Reporting)
United Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/24/2025
3:32 PM | MAHON PAUL A (Reporting)
United Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
07/14/2025
3:30 PM | MAHON PAUL A (Reporting)
United Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/10/2025
3:22 PM | MAHON PAUL A (Reporting)
United Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
06/27/2025
3:39 PM | MAHON PAUL A (Reporting)
United Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
Get the Latest News and Ratings for UTHR and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for United Therapeutics and its competitors with MarketBeat's FREE daily newsletter. |
06/27/2025
6:30 AM | United Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/26/2025
4:36 PM | MAHON PAUL A (Reporting)
United Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
06/25/2025
3:36 PM | Giltner Richard (Reporting)
United Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/25/2025
3:38 PM | Mesa Nilda (Reporting)
United Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/24/2025
4:25 PM | Mesa Nilda (Reporting)
United Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
06/24/2025
3:57 PM | Giltner Richard (Reporting)
United Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
06/16/2025
7:48 AM | MAHON PAUL A (Reporting)
United Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/03/2025
3:30 PM | EDGEMOND JAMES (Reporting)
United Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/02/2025
3:39 PM | EDGEMOND JAMES (Reporting)
United Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
05/12/2025
3:30 PM | Thompson Tommy G (Reporting)
United Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/12/2025
9:44 AM | United Therapeutics (Subject)
WELLINGTON MANAGEMENT GROUP LLP (Filed by)
| Form SCHEDULE 13G/A | |
05/02/2025
3:31 PM | MAHON PAUL A (Reporting)
United Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/30/2025
5:32 AM | United Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
04/30/2025
5:33 AM | United Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/29/2025
5:31 AM | United Therapeutics (Filer)
| Form DEF 14A | |
04/29/2025
5:33 AM | United Therapeutics (Filer)
| Form DEFA14A | |
04/29/2025
5:36 AM | United Therapeutics (Filer)
| Form ARS | |
04/28/2025
5:31 AM | United Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/22/2025
3:30 PM | DWEK RAYMOND (Reporting)
United Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/15/2025
3:28 PM | DWEK RAYMOND (Reporting)
United Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/14/2025
3:02 PM | DWEK RAYMOND (Reporting)
United Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
04/07/2025
3:01 PM | DWEK RAYMOND (Reporting)
United Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
04/07/2025
8:05 AM | MAHON PAUL A (Reporting)
United Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/25/2025
3:31 PM | Thompson Tommy G (Reporting)
United Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/24/2025
3:47 PM | Thompson Tommy G (Reporting)
United Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/20/2025
5:11 PM | PATUSKY CHRISTOPHER (Reporting)
United Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/19/2025
3:11 PM | PATUSKY CHRISTOPHER (Reporting)
United Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/11/2025
3:30 PM | BENKOWITZ MICHAEL (Reporting)
United Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/11/2025
3:31 PM | ROTHBLATT MARTINE A (Reporting)
United Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/07/2025
3:33 PM | MAHON PAUL A (Reporting)
United Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
"I'm risking my reputation on this" (Ad) A massive supply shock is building in the crypto market that could send Bitcoin to $300,000 this year.
That's why we've rushed to update our book "Crypto Revolution" – to show you exactly how to position yourself for this historic opportunity. Click here to claim your FREE copy now! |
03/04/2025
3:41 PM | BENKOWITZ MICHAEL (Reporting)
United Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/03/2025
3:31 PM | KURZWEIL RAY (Reporting)
United Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/28/2025
3:34 PM | Thompson Tommy G (Reporting)
United Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/26/2025
5:33 AM | United Therapeutics (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
02/26/2025
5:35 AM | United Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/25/2025
3:30 PM | BENKOWITZ MICHAEL (Reporting)
United Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/21/2025
3:30 PM | MAHON PAUL A (Reporting)
United Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/19/2025
3:30 PM | BENKOWITZ MICHAEL (Reporting)
United Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/11/2025
3:32 PM | BENKOWITZ MICHAEL (Reporting)
United Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/10/2025
9:25 AM | United Therapeutics (Subject)
WELLINGTON MANAGEMENT GROUP LLP (Filed by)
| Form SCHEDULE 13G/A | |
02/05/2025
6:10 AM | STATE STREET CORP (Filed by)
United Therapeutics (Subject)
| Form SCHEDULE 13G | |
01/22/2025
3:30 PM | BENKOWITZ MICHAEL (Reporting)
United Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/14/2025
3:31 PM | BENKOWITZ MICHAEL (Reporting)
United Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/13/2025
3:30 PM | BENKOWITZ MICHAEL (Reporting)
United Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/13/2025
3:30 PM | PATUSKY CHRISTOPHER (Reporting)
United Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/13/2025
7:57 AM | United Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/10/2025
3:29 PM | PATUSKY CHRISTOPHER (Reporting)
United Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/07/2025
3:30 PM | BENKOWITZ MICHAEL (Reporting)
United Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/31/2024
3:31 PM | Mesa Nilda (Reporting)
United Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/31/2024
3:32 PM | BENKOWITZ MICHAEL (Reporting)
United Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/30/2024
3:08 PM | Mesa Nilda (Reporting)
United Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
12/26/2024
3:30 PM | BENKOWITZ MICHAEL (Reporting)
United Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/20/2024
3:31 PM | MAHON PAUL A (Reporting)
United Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/18/2024
4:51 PM | SULLIVAN LOUIS W (Reporting)
United Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
12/17/2024
3:31 PM | BENKOWITZ MICHAEL (Reporting)
United Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/16/2024
3:38 PM | BENKOWITZ MICHAEL (Reporting)
United Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
12/10/2024
3:32 PM | BENKOWITZ MICHAEL (Reporting)
United Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/03/2024
3:30 PM | BENKOWITZ MICHAEL (Reporting)
United Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/27/2024
5:44 AM | BENKOWITZ MICHAEL (Reporting)
United Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/22/2024
4:37 PM | MAHON PAUL A (Reporting)
United Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/18/2024
4:04 PM | BENKOWITZ MICHAEL (Reporting)
United Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
11/12/2024
10:32 AM | Olian Judy D. (Reporting)
United Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
11/08/2024
3:17 PM | Mesa Nilda (Reporting)
United Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
11/06/2024
4:07 PM | BENKOWITZ MICHAEL (Reporting)
United Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
11/05/2024
3:30 PM | EDGEMOND JAMES (Reporting)
United Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/05/2024
3:33 PM | Giltner Richard (Reporting)
United Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
11/01/2024
3:45 PM | CAUSEY CHRISTOPHER (Reporting)
United Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
11/01/2024
3:23 PM | BENKOWITZ MICHAEL (Reporting)
United Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
10/30/2024
5:32 AM | United Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
10/30/2024
5:34 AM | United Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/29/2024
3:30 PM | EDGEMOND JAMES (Reporting)
United Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/28/2024
3:13 PM | EDGEMOND JAMES (Reporting)
United Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
10/22/2024
3:30 PM | EDGEMOND JAMES (Reporting)
United Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/18/2024
4:19 PM | MAHON PAUL A (Reporting)
United Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/16/2024
12:03 PM | STATE STREET CORP (Filed by)
United Therapeutics (Subject)
| Form SC 13G | |
10/15/2024
3:30 PM | EDGEMOND JAMES (Reporting)
United Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/15/2024
7:19 AM | EDGEMOND JAMES (Reporting)
United Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
10/08/2024
3:30 PM | EDGEMOND JAMES (Reporting)
United Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/24/2024
3:30 PM | EDGEMOND JAMES (Reporting)
United Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/23/2024
3:30 PM | MAHON PAUL A (Reporting)
United Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
"I'm risking my reputation on this" (Ad) A massive supply shock is building in the crypto market that could send Bitcoin to $300,000 this year.
That's why we've rushed to update our book "Crypto Revolution" – to show you exactly how to position yourself for this historic opportunity. Click here to claim your FREE copy now! |
09/17/2024
3:30 PM | EDGEMOND JAMES (Reporting)
United Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/17/2024
3:30 PM | Olian Judy D. (Reporting)
United Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/16/2024
3:20 PM | EDGEMOND JAMES (Reporting)
United Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
09/10/2024
3:30 PM | EDGEMOND JAMES (Reporting)
United Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/05/2024
3:30 PM | PATUSKY CHRISTOPHER (Reporting)
United Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/04/2024
3:34 PM | EDGEMOND JAMES (Reporting)
United Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/03/2024
3:35 PM | PATUSKY CHRISTOPHER (Reporting)
United Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
09/03/2024
3:18 PM | EDGEMOND JAMES (Reporting)
United Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
08/28/2024
3:30 PM | ROTHBLATT MARTINE A (Reporting)
United Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
MarketBeat All Access